| Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells (NCT04382547) | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | 2020-05-11 |
| First-in-Human Study of XMT-1592 in Patients With Ovarian Cancer and NSCLC Likely to Express NaPi2b (NCT04396340) | Mersana Therapeutics | 2020-05-11 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics of ALZ002 DS in Healthy Volunteers (NCT04392830) | AnnJi Pharmaceutical Co., Ltd. | 2020-05-11 |
| A Trial of ZL-1201 in Subjects With Advanced Cancer (NCT04257617) | Zai Lab (Shanghai) Co., Ltd. | 2020-05-11 |
| A Phase I/II Study of TJ004309 for Advanced Solid Tumor (NCT04322006) | TJ Biopharma Co., Ltd. | 2020-05-09 |
| Safety and Efficacy of ThisCART19 in Patients With Refractory or Relapsed B Cell Malignancies (NCT04384393) | Fundamenta Therapeutics, Ltd. | 2020-05-09 |
| DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST) (NCT04276415) | Daiichi Sankyo | 2020-05-08 |
| Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19) (NCT04372004) | Texas Cardiac Arrhythmia Research Foundation | 2020-05-08 |
| Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies (NCT04361708) | University of Chicago | 2020-05-08 |
| Dose-Escalation Study of HTX-034 Following Bunionectomy (NCT04398329) | Heron Therapeutics | 2020-05-08 |
| Continuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms (NCT04196010) | University of Washington | 2020-05-08 |
| Pd-1 Antibody Combined CCRT for Local Advanced Cervical Cancer. (NCT04368273) | Peking University Third Hospital | 2020-05-08 |
| Safety in Convalescent Plasma Transfusion to COVID-19 (NCT04333355) | TecSalud Investigación Clínica | 2020-05-08 |
| Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT04384146) | Memorial Sloan Kettering Cancer Center | 2020-05-07 |
| Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study (NCT04384497) | Joakim Dillner | 2020-05-07 |
| Randomized, Crossover Bioequivalence Study of PL-ASA Versus Immediate Release Aspirin in Healthy Volunteers. (NCT05055752) | PLx Pharma | 2020-05-07 |
| A Study of TY-9591 in Advanced Non-small Cell Lung Cancer(NSCLC) Patients With EGFR Positive Mutation (NCT04204473) | TYK Medicines, Inc | 2020-05-07 |
| A Study Combining the Peposertib (M3814) Pill With Standard Chemotherapy in Patients With Ovarian Cancer With an Expansion in High Grade Serous Ovarian Cancer and Low Grade Serous Ovarian Cancer (NCT04092270) | National Cancer Institute (NCI) | 2020-05-07 |
| An in Vivo Bioequivalence Study of 2 Loxoprofen Sodium Products in Vietnamese Healthy Male Volunteers (NCT04386122) | Centre of Clinical Pharmacology, Hanoi Medical University | 2020-05-07 |
| A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary) (NCT04521751) | Empros Pharma AB | 2020-05-07 |
| A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150 (NCT04334213) | Chong Kun Dang Pharmaceutical | 2020-05-07 |
| Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors (NCT04344795) | Tempest Therapeutics | 2020-05-06 |
| Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients (NCT04336254) | Renmin Hospital of Wuhan University | 2020-05-06 |
| A Food Effect Study of FMTN on Healthy Chinese Adult Subjects (NCT04616716) | Jiangsu HengRui Medicine Co., Ltd. | 2020-05-06 |
| RTX-240 Monotherapy and in Combination With Pembrolizumab (NCT04372706) | Rubius Therapeutics | 2020-05-06 |
| Revisiting the Mechanism of the Anti-inflammatory Effect of Colchicine (NCT04355585) | Brigham and Women's Hospital | 2020-05-06 |
| SVF for Treating Pulmonary Fibrosis Post COVID-19 (NCT06304623) | Michael H Carstens | 2020-05-05 |
| Leflunomide in Mild COVID-19 Patients (NCT04361214) | University of Chicago | 2020-05-05 |
| A Study to Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated Cancers (NCT04272203) | AbbVie | 2020-05-05 |
| Testing the Addition of an Anti-cancer Drug, M3814, to the Usual Treatment (Mitoxantrone, Etoposide, and Cytarabine) for Relapsed or Refractory Acute Myeloid Leukemia (NCT03983824) | National Cancer Institute (NCI) | 2020-05-05 |
| SINUS WASH Pilot Study in Adults Testing Positive for COVID-19 (NCT04393792) | Hampshire Hospitals NHS Foundation Trust | 2020-05-05 |
| Low Dose Radiotherapy in COVID-19 Pneumonia (NCT04390412) | Shahid Beheshti University of Medical Sciences | 2020-05-04 |
| Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory (NCT03969446) | City of Hope Medical Center | 2020-05-04 |
| WP1066 in Children With Refractory and Progressive or Recurrent Malignant Brain Tumors (NCT04334863) | Emory University | 2020-05-04 |
| A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors (NCT04303858) | Hoffmann-La Roche | 2020-05-04 |
| A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients (NCT04369846) | Xantho Biotechnology Co., LTD | 2020-05-04 |
| Intravenous Ketamine Effects on Functional Neuroanatomy (NCT04205890) | Neurological Associates of West Los Angeles | 2020-05-02 |
| Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs (NCT04461925) | Institute of Cell Therapy | 2020-05-02 |
| Multiple Ascending Doses of SY-009 in Type 2 Diabetes Mellitus (NCT04345107) | Suzhou Yabao Pharmaceutical R&D Co., Ltd. | 2020-05-01 |
| Modulating Effects of Oil Palm Phenolics in Subjects With Pre-diabetes (NCT02532088) | Universiti Sains Malaysia | 2020-05-01 |
| The Tolerance,Pharmacokinetic Characteristics,Safety and Efficacy of ScTIL210 in the Treatment of Melanoma (NCT04357509) | Peking University Cancer Hospital & Institute | 2020-05-01 |
| A Study of SSS17 in Healthy Subjects (NCT04317833) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2020-05-01 |
| COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo) (NCT04389385) | TC Erciyes University | 2020-05-01 |
| A Clinical Study to Assess the Effect of Change of Bile Acid on the PD and Safety of Metformin and Microbiome Profiles (NCT04335526) | Seoul National University Hospital | 2020-05-01 |
| A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma (NCT04356846) | The First Affiliated Hospital with Nanjing Medical University | 2020-05-01 |
| Autologous TAC T Cells Targeting CD19 in R/R Large B-Cell Lymphoma (NCT03880279) | Triumvira Immunologics, Inc. | 2020-05-01 |
| Microwave Ablation of Primary and Secondary Lung Malignancies (NCT04369872) | University of Calgary | 2020-05-01 |
| Pharmacokinetic Interaction and Safety Between NVP-1203-R1 and NVP-1203-R2 (NCT04181437) | NVP Healthcare | 2020-05-01 |
| The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients (NCT04410341) | Sadat City University | 2020-05-01 |
| Tocilizumab in COVID-19 Lahore General Hospital (NCT04560205) | Lahore General Hospital | 2020-05-01 |
| Effect Of Moringa Leaf Extract On Disease Activity In Rheumatoid Arthritis Patients (NCT05665985) | Universitas Sebelas Maret | 2020-05-01 |
| Efficacy and Safety of MTX-loaded Nanoparticles to Treat Severe COVID-19 Patients (NCT04352465) | Azidus Brasil | 2020-05-01 |
| Convalescent Plasma Therapy in Patients With COVID-19 (NCT04407208) | Biofarma | 2020-05-01 |
| Lorlatinib Combinations in Lung Cancer (NCT04292119) | Massachusetts General Hospital | 2020-05-01 |
| Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion (NCT03275792) | University of Calgary | 2020-05-01 |
| Evaluate the Safety, Immunologic, and Virologic Responses of Donor Derived (DD) HIV-Specific T-cells (HST) in HIV-infected Individuals Following Allogeneic Bone Marrow Transplantation (alloRESIST) (NCT04248192) | Catherine Bollard | 2020-05-01 |
| ACT-20 in Patients With Severe COVID-19 Pneumonia (NCT04398303) | Aspire Health Science | 2020-05-01 |
| Novel MRI-Guided Ultrasound Stimulated Microbubble Radiation Treatment for Patients With Head and Neck Cancer (NCT04431648) | Sunnybrook Health Sciences Centre | 2020-05-01 |
| Bioequivalence Study of Lopinavir/Ritonavir 200/50 mg Film Tablet (World Medicine Ilac, Turkey) Under Fasting Conditions (NCT04386876) | World Medicine ILAC SAN. ve TIC. A.S. | 2020-04-30 |
| A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants With Relapsed/Refractory Multiple Myeloma (NCT04171843) | Precision BioSciences, Inc. | 2020-04-30 |
| COVID-19 Convalescent Plasma for Mechanically Ventilated Population (NCT04388527) | University of Pennsylvania | 2020-04-30 |
| CyPep-1 Injections in Cancer Inducing Lymphocyte Infiltrate Accumulations (NCT04260529) | Cytovation AS | 2020-04-30 |
| A Study of Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4 (NCT04274738) | X4 Pharmaceuticals | 2020-04-30 |
| Gene Therapy Trial for Platelet Derived Factor VIII Production in Hemophilia A (NCT03818763) | Medical College of Wisconsin | 2020-04-29 |
| Clinical Study of in Situ Regeneration of Endometrium (NCT04233892) | Yali Hu | 2020-04-29 |
| Inhibition Metamizole 2020 (NCT04621253) | University Hospital, Basel, Switzerland | 2020-04-29 |
| CPX-351 in Higher Risk Myelodysplastic Syndromes (NCT04273802) | Groupe Francophone des Myelodysplasies | 2020-04-29 |
| Study of Acalabrutinib in Chinese Adult Subjects With Relapsed or Refractory Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia or Other B-cell Malignancies (NCT03932331) | AstraZeneca | 2020-04-29 |
| Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab (NCT04282018) | BeiGene | 2020-04-29 |
| Convalescent Plasma Therapy - Zurich Protocol (NCT04869072) | University of Zurich | 2020-04-29 |
| Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers (NCT04324905) | Hanmi Pharmaceutical Company Limited | 2020-04-29 |
| Allogeneic BM-MSCs in Patients with Lumbar Facet Arthropathy (NCT04410731) | Mayo Clinic | 2020-04-28 |
| Safety, Tolerability and Pharmacokinetics of a Recombinant Humanized mAb Specific to B-and T-Lymphocyte Attenuator (BTLA) for Injection in Subjects With Advanced Malignancies (NCT04278859) | Shanghai Junshi Bioscience Co., Ltd. | 2020-04-28 |
| A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor (NCT04802980) | Huabo Biopharm Co., Ltd. | 2020-04-28 |
| AMG 510 Ethnic Sensitivity Study (CodeBreaK 105). (NCT04380753) | Amgen | 2020-04-28 |
| Immunotherapy for the Treatment of Advanced Solid Tumor (NCT03658785) | Tongji Hospital | 2020-04-28 |
| Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 Administered to Previously Treated Adults C9ORF72-Associated Amyotrophic Lateral Sclerosis (ALS) (NCT04288856) | Biogen | 2020-04-28 |
| Evaluating the Safety and Efficacy of Autologous Adipose Tissue-derived Mesenchymal Stem Cell Transplantation on Proinflammatory Cytokines and Anti-inflammatory Cytokines on Ageing-related Low-grade Inflammation Patients. (NCT05827757) | DNA International Hospital | 2020-04-28 |
| Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed . (NCT04099303) | CanSino Biologics Inc. | 2020-04-28 |
| Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 (NCT04366323) | Andalusian Network for Design and Translation of Advanced Therapies | 2020-04-27 |
| Progesterone for the Treatment of COVID-19 in Hospitalized Men (NCT04365127) | Sara Ghandehari | 2020-04-27 |
| Single and Multiple Dose Study of Miricorilant (CORT118335) Tablet Formulations in Healthy Participants (NCT04672499) | Corcept Therapeutics | 2020-04-27 |
| To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer (NCT04332549) | Sun Pharma Advanced Research Company Limited | 2020-04-27 |
| A Phase 1 Study of CX1003 (Kanitinib) in Patients with Advanced Solid Tumors (NCT04093466) | Beijing Konruns Pharmaceutical Co., Ltd. | 2020-04-27 |
| A Phase I/II Study of XELOXIRI and Bevacizumab as First-line Treatment in Metastatic Colorectal Cancer (NCT04380103) | Chinese Academy of Medical Sciences | 2020-04-26 |
| Phase I/II Study of SY-3505 in Patients With ALK-positive Advanced Non-small Cell Lung Cancer (NCT05257512) | Shouyao Holdings (Beijing) Co. LTD | 2020-04-26 |
| Use of UC-MSCs for COVID-19 Patients (NCT04355728) | Camillo Ricordi | 2020-04-25 |
| A Phase I Clinical Trial of Meplazumab in Healthy Volunteer (NCT04369586) | Xijing Hospital | 2020-04-25 |
| A Study of CSPCHA131 in Patients With Advanced Solid Tumor (NCT04325711) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-04-24 |
| COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy (NCT04933864) | I.M. Sechenov First Moscow State Medical University | 2020-04-24 |
| A Study of TTYP01 in Healthy Adult Subjects (NCT04370431) | Shanghai Auzone Biological Technology Co., Ltd. | 2020-04-24 |
| Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia (NCT04131426) | University of Rochester | 2020-04-24 |
| Mesenchymal Stem Cells for the Treatment of COVID-19 (NCT04573270) | Thomas Advanced Medical LLC | 2020-04-24 |
| Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 (NCT04366791) | Emory University | 2020-04-24 |
| Toripalimab Plus Rituximab Followed by R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma (NCT04058470) | Huiqiang Huang | 2020-04-24 |
| SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON) (NCT04291079) | Scholar Rock, Inc. | 2020-04-23 |
| ATG-008 Combined With Toripalimab in Advanced Solid Tumors (NCT04337463) | Sichuan University | 2020-04-23 |
| Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection (NCT04366245) | Andalusian Network for Design and Translation of Advanced Therapies | 2020-04-23 |
| Clinical Trial to Evaluate Light-induced Skin Reactions After Application of Delgocitinib Cream (NCT04361136) | LEO Pharma | 2020-04-23 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending and Multiple Doses of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Healthy Japanese Participants (NCT04302064) | Ionis Pharmaceuticals, Inc. | 2020-04-23 |